C16H12F3NO, orthorhombic, P212121 (no. 19), a = 6.9928(6) Å, b = 8.9764(8) Å, c = 21.216(2) Å, V = 1331.7(2) Å3, Z = 2, Rgt(F) = 0.0583, wRref(F2) = 0.1552, T = 298 K
In the title compound, C14H17FN2O, the 1,2,3,4-tetrahydropyridine ring of the quinoline moiety adopt...
C14H11N3O, triclinic, P1̅ (no. 2), a = 9.0506(8) Å, b = 11.362(1) Å, c = 11.486(1) Å, α = 88.137(7)°...
C16H11Cl2FN2, orthorhombic, Pbca (no. 61), a = 9.6732(3) Å, b = 15.5602(5) Å, c = 19.0881(6) Å, V = ...
C18H13F2NO4, triclinic, P1̄ (no. 2), a = 7.9002(13) Å, b = 9.9371(16) Å, c = 10.6852(17) Å, α = 101....
C15H11ClFN3O2, monoclinic, P21/c (no. 14), a = 12.9430(8) Å, b = 9.3196(5) Å, c = 12.5959(8) Å, β = ...
C14H14F6N2O, orthorhombic, Pbcn (no. 60), a = 17.7552(12) Å, b = 10.7574(9) Å, c = 8.0207(7) Å, V = ...
C18H14F2N2O4, triclinic, P1̄ (no. 2), a = 6.377(3) Å, b = 9.466(5) Å, c = 13.367(7) Å, α = 83.409(6)...
C27H32FN3O9, triclinic, P1‾$P\overline{1}$ (no. 2), a = 8.0932(4) Å, b = 11.8392(7) Å, c = 14.6782(8...
C18H12ClF2NO4, monoclinic, P21/c (no. 14), a = 13.544(5) Å, b = 9.344(3) Å, c = 13.545(5) Å, β = 109...
C20H18ClF4N3O, monoclinic, P21/c (no. 14), a = 9.6123(7) Å, b = 11.8692(7) Å, c = 16.9510(12) Å, β =...
C17H15NO, monoclinic, C2/c (no. 15), a = 19.197(2) Å, b = 8.0719(8) Å, c = 16.6511(18) Å, α = 90°, β...
C19H17FN4O, orthorhombic, Pbca (no. 61), a = 7.0607(2) Å, b = 18.4459(5) Å, c = 23.8955(7) Å, V = 31...
C16H13FN2O2, triclinic, P1̅ (no. 2), a = 8.7809(6) Å, b = 8.7912(6) Å, c = 10.0170(7) Å, α = 72.048(...
C20H21F2NO4, triclinic, P1‾$P‾{1}$ (no. 2), a = 8.6363(11) Å, b = 9.9144(11) Å, c = 11.8734(1...
C13H11FN2O3, triclinic, P1̅, a = 5.7471(4) Å, b = 7.8734(6) Å, c = 13.3112(11) Å, α = 75.546(3)°,...
In the title compound, C14H17FN2O, the 1,2,3,4-tetrahydropyridine ring of the quinoline moiety adopt...
C14H11N3O, triclinic, P1̅ (no. 2), a = 9.0506(8) Å, b = 11.362(1) Å, c = 11.486(1) Å, α = 88.137(7)°...
C16H11Cl2FN2, orthorhombic, Pbca (no. 61), a = 9.6732(3) Å, b = 15.5602(5) Å, c = 19.0881(6) Å, V = ...
C18H13F2NO4, triclinic, P1̄ (no. 2), a = 7.9002(13) Å, b = 9.9371(16) Å, c = 10.6852(17) Å, α = 101....
C15H11ClFN3O2, monoclinic, P21/c (no. 14), a = 12.9430(8) Å, b = 9.3196(5) Å, c = 12.5959(8) Å, β = ...
C14H14F6N2O, orthorhombic, Pbcn (no. 60), a = 17.7552(12) Å, b = 10.7574(9) Å, c = 8.0207(7) Å, V = ...
C18H14F2N2O4, triclinic, P1̄ (no. 2), a = 6.377(3) Å, b = 9.466(5) Å, c = 13.367(7) Å, α = 83.409(6)...
C27H32FN3O9, triclinic, P1‾$P\overline{1}$ (no. 2), a = 8.0932(4) Å, b = 11.8392(7) Å, c = 14.6782(8...
C18H12ClF2NO4, monoclinic, P21/c (no. 14), a = 13.544(5) Å, b = 9.344(3) Å, c = 13.545(5) Å, β = 109...
C20H18ClF4N3O, monoclinic, P21/c (no. 14), a = 9.6123(7) Å, b = 11.8692(7) Å, c = 16.9510(12) Å, β =...
C17H15NO, monoclinic, C2/c (no. 15), a = 19.197(2) Å, b = 8.0719(8) Å, c = 16.6511(18) Å, α = 90°, β...
C19H17FN4O, orthorhombic, Pbca (no. 61), a = 7.0607(2) Å, b = 18.4459(5) Å, c = 23.8955(7) Å, V = 31...
C16H13FN2O2, triclinic, P1̅ (no. 2), a = 8.7809(6) Å, b = 8.7912(6) Å, c = 10.0170(7) Å, α = 72.048(...
C20H21F2NO4, triclinic, P1‾$P‾{1}$ (no. 2), a = 8.6363(11) Å, b = 9.9144(11) Å, c = 11.8734(1...
C13H11FN2O3, triclinic, P1̅, a = 5.7471(4) Å, b = 7.8734(6) Å, c = 13.3112(11) Å, α = 75.546(3)°,...
In the title compound, C14H17FN2O, the 1,2,3,4-tetrahydropyridine ring of the quinoline moiety adopt...
C14H11N3O, triclinic, P1̅ (no. 2), a = 9.0506(8) Å, b = 11.362(1) Å, c = 11.486(1) Å, α = 88.137(7)°...
C16H11Cl2FN2, orthorhombic, Pbca (no. 61), a = 9.6732(3) Å, b = 15.5602(5) Å, c = 19.0881(6) Å, V = ...